Cindy Lee
CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: A refined target for radiotherapy trials?: Correspondence
Lee, Cindy; Guinn, Barbara Ann; Brooks, Suzanne E.; Richardson, Deborah; Orchard, Kim
Authors
Dr Barbara Guinn B.Guinn@hull.ac.uk
Reader in Biomedical Sciences
Suzanne E. Brooks
Deborah Richardson
Kim Orchard
Citation
Lee, C., Guinn, B. A., Brooks, S. E., Richardson, D., & Orchard, K. (2010). CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: A refined target for radiotherapy trials?: Correspondence. British journal of haematology, 149(5), 795-796. https://doi.org/10.1111/j.1365-2141.2010.08100.x
| Journal Article Type | Letter |
|---|---|
| Online Publication Date | Mar 8, 2010 |
| Publication Date | Jun 1, 2010 |
| Deposit Date | Apr 4, 2022 |
| Journal | British Journal of Haematology |
| Print ISSN | 0007-1048 |
| Publisher | Wiley |
| Peer Reviewed | Peer Reviewed |
| Volume | 149 |
| Issue | 5 |
| Pages | 795-796 |
| DOI | https://doi.org/10.1111/j.1365-2141.2010.08100.x |
| Keywords | CD66; Multiple myeloma; Plasma cells; Targeted radiotherapy |
| Public URL | https://hull-repository.worktribe.com/output/3586994 |
You might also like
Immunotherapeutic Potential of Mutated NPM1 for the Treatment of Acute Myeloid Leukemia
(2024)
Journal Article